Clinical Trials Sponsored by Theranos, Inc.

Total 35387 results

Stanford University
Theranos, Inc.

Completed

Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias

Leukemia, Myeloid | Leukemia, Lymphocytic

United States
Theracos

Completed

Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Type2 Diabetes Mellitus

United States, Japan
Theracos

Completed

Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection

Type2 Diabetes Mellitus

United States
Theracos

Completed

Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

Germany, United States, Spain, Poland
Theracos

Completed

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

Essential Hypertension

United States
Theracos

Completed

Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin

Type2 Diabetes Mellitus

United States
Theracos

Completed

Bexagliflozin Efficacy and Safety Trial (BEST)

Type 2 Diabetes Mellitus

United States, Canada, Czechia, Denmark, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Taiwan
Theracos

Completed

Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States
Theracos

Completed

Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers

Safety and Tolerability of EGT0001474 in Healthy Volunteers

United States
Thrasos Innovation, Inc.

Completed

A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)

Acute Kidney Injury

United States, Canada
Theracos

Completed

Bexagliflozin Drug/Drug Interaction Study With Digoxin

Type2 Diabetes Mellitus

United States
Theracos

Completed

Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
Theracos

Completed

Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment

Type 2 Diabetes Mellitus

United States, France, Spain, Japan
Theracos

Completed

A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States, Japan
Theracos

Completed

Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Canada
Theracos

Completed

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus

United States, Japan, Czechia, Hungary, Poland, Spain
Theracos

Completed

Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus Type 2

United States, Canada
Theracos

Completed

Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
Theracos

Completed

Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment

Type2 Diabetes Mellitus

United States
Theracos

Withdrawn

Absolute Bioavailability Study With Bexagliflozin

Type 2 Diabetes Mellitus

United States
Theracos

Completed

Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy Subjects

Obesity
Theracos

Completed

Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes

Diabetes Mellitus Type 2

United States
TheRas, Inc

Recruiting

Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

NSCLC | Metastatic Lung Cancer | Non-small Cell Lung Cancer | Advanced Lung Carcinoma | Metastatic Non-Small Cell Lung Cancer | KRAS G12C

United States
Theranor s.p.r.l

Completed

Efficacy and Safety Study of Homeopathic Oral Antibodies to Treat Viral Upper Respiratory Tract Infections (ESTUAR)

Common Cold

Belgium
Therakos, Inc., a Mallinckrodt Company

Terminated

Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host Disease

Steroid Refractory Acute Graft Versus Host Disease

United States, Spain, France, Austria, Germany, Hungary, Italy, United Kingdom
TheraOp

Active, not recruiting

MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab

Adenocarcinoma of the Rectum | Adenocarcinoma of the Colon

Germany
Theranova, L.L.C.

Completed

Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain

Episodic Migraine

United States
Theranova, L.L.C.

Completed

Treatment Parameters for the Empower Neuromodulation System (ENS) (AUD1)

Alcohol Use Disorder

United States
Theranova, L.L.C.

Recruiting

EMPOWER AUD Pivotal Trial

Alcoholism | Alcohol Use Disorder | Alcohol Abuse

United States
Theranova, L.L.C.

Completed

Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms

Overactive Bladder

United States
Theranova, L.L.C.

Unknown

Comparing PA Compliance During and After Decompensation in HFP

Congestive Heart Failure | Decompensated Heart Failure

United States
TheraOp
AstraZeneca

Active, not recruiting

PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC (PACCELIO)

Stage III Non-small Cell Lung Cancer | Locally Advanced | Unresectable

Switzerland
Theracos
TFS Trial Form Support

Completed

Efficacy and Safety of THR-4109 in Obese Subjects

Obesity

Russian Federation, Sweden
Theranova, L.L.C.

Completed

Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms

Overactive Bladder

United States
Theranova, L.L.C.
Stanford University

Completed

Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home (OAB Aim 2)

Overactive Bladder

United States
Theranova, L.L.C.
University of Nebraska

Completed

Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women--Aim 2

Osteopenia

United States
NicOx
Theradis pharma; Iris Pharma

Withdrawn

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) (Goldeneye)

Adenoviral Conjunctivitis

Spain
TcLand Expression S.A.
Premier Research Group plc; Theradis pharma; Medpharmgene, Inc.

Terminated

Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy (PRINT)

Rheumatoid Arthritis

Canada, France, Hungary, Italy, Lithuania, Romania, Slovakia, Spain
Theranova, L.L.C.
National Institute on Aging (NIA); University of Nebraska

Active, not recruiting

Evaluation of the Spry Belt for Improving Bone Quality

Osteopenia

United States
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
Theranova, L.L.C.
National Center for Complementary and Integrative Health (NCCIH); University...

Terminated

Empower Neuromodulation System - Pilot Study for Anxiety Treatment

Generalized Anxiety Disorder

United States
Pharnext S.C.A.
Premier Research Group plc; Eurofins Optimed; Synteract HCR (Syneos Health); Gr... and other collaborators

Active, not recruiting

Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A (PLEO-CMT-FU)

Charcot-Marie-Tooth Disease, Type IA

United States, Belgium, Canada, France, Netherlands, Spain, United Kingdom
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.; Oncoceutics, Inc.

Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Metastasis | Endometrial Cancer

United States
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
Theranova, L.L.C.
National Institute on Drug Abuse (NIDA); Northern California Institute of Research...

Active, not recruiting

Pilot Research on Opioid Use Disorder (PROUD)

Opioid-use Disorder

United States
Laminar Pharmaceuticals
Laboratory Corporation of America; Northern Institute for Cancer Research,... and other collaborators

Recruiting

LAM561 With RT and TMZ for Adults With Glioblastoma (CLINGLIO)

Glioblastoma Multiforme | Primary Glioblastoma

Spain, Italy, United Kingdom, France, Israel
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States

Clinical Trials Sponsored by Theranos, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations